摘要
5 氟尿嘧啶 (5 FU)是常用化疗药物之一 ,在个体治疗中存在着疗效不确定性和毒副作用。二氢嘧啶脱氢酶 (DPD)是 5 FU代谢的限速酶 ,在其分解代谢中起关键作用。现综述DPD的研究进展以及DPD检测在 5 FU化疗中的意义。
出处
《国外医学（肿瘤学分册）》
2004年第2期120-121,共2页
Foreign Medical Sciences (Cancer Section)
基金
浙江省科技厅基金资助项目 ( 0 1110 3 994)
参考文献10
-
1Mattison LK,Johnson MR,Diasio RB.A comparative analysis of translated dihydropyrimidine dehydrogenase cDNA; conservation of functional domains and relevance to genetic polymorphisms.Pharmacogenetics,2002,12(2):133-144.
-
2Tokunaga Y,Nakagami M,Tokuka A,et al.Prognostic effects of dihydropyrimidine dehydrogenase in advanced colorectal cancer after surgery:immunohistochemistry using a new monoclonal antibody.Anticancer Res,2003,23(2C):1763-1768.
-
3Shirota Y,Ichikawa W,Uetake H,et al.Intratumoral dihydropyrimidine dehydrogenase messenger RNA level reflects tumor progression in human colorectal cancer.Ann Surg Oncol,2002,9(6):599-603.
-
4Nishimura G,Terada I,Kobayashi T,et al.Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy.Oncol Rep,2002,9(3):479-482.
-
5Nozawa H,Tsukui H,Nishida K,et al.Dihydropyrimidine dehydrogenase expression in preoperative biopsy and surgically resected specimens of gastric carcinoma.Cancer Chemother Pharmacol,2002,49(4):267-273.
-
6Di Paolo A,Danesi R,Falcone A,et al.Relationship between 5-fluorouracil disposition,toxicity and dihydropyrimidine dehydrogenaseactivity in cancer patients.Ann Oncol,2001,12(9):1301-1306.
-
7Takiguchi N,Koda K,Ooshima H,et al.Dihydropyrimidine dehydrogenase-related enzymes predict efficacy and adverse reactions of UFT1 + cisplatin neoadjuvant chemotherapy for gastric cancer.Anticancer Drugs,2002,13(4):411-416.
-
8Terashima M,Fujiwara H,Takagane A,et al.Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer.Gastric Cancer,2003,6(Suppl 1) :71-81.
-
9Ichikawa W,Uetake H,Shirota Y,et al.Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.Clin Cancer Res,2003,9(2):786-791.
-
10Ishibiki Y,Kitajima M,Sakamoto K,et al.Intratumoural thymidylate synthase and dihydropyrimidine dehydrogenase activities are good predictors of 5-fluorouracil sensitivity in colorectal cancer,J Int Med Res,2003,31(3):181-187.
同被引文献3
-
1李倩玉,王一.恶性肿瘤化疗耐药评价体系的研究进展[J].国外医学（肿瘤学分册）,2005,32(5):355-358. 被引量：1
-
2Miwa M,Ura M,Nishida M,et al.Design of a novel oral fluoropy rmidene carbamate,carecitabine,which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue[J].Eur J cancer,1998,34(8):1274-1281.
-
3王洁,刘叙仪.抗肿瘤新靶点药物及其临床应用前景[J].国外医学（肿瘤学分册）,2001,28(5):326-329. 被引量：10
-
1户庄,马明德,周振宇,王亚威.环磷酰胺联合甲氨蝶呤及氟尿嘧啶治疗晚期乳腺癌52例[J].中国实用医刊,2013,40(16):71-72.
-
2陈良峰.奥沙利铂亚叶酸钙和氟尿嘧啶在晚期结直肠癌中的疗效观察[J].中国伤残医学,2013,21(8):259-260.
-
3乔天奎,辛立,刘海燕,常军,张本华.卡铂、氟尿嘧啶化疗结合放射治疗非小细胞肺癌疗效分析[J].中华结核和呼吸杂志,1999,22(9):536-537. 被引量：6
-
4付国权,蒋代文,张文涛.伊立替康治疗直肠癌肺转移35例[J].医药导报,2008,27(12):1477-1477. 被引量：1
-
5何小进,马进安,赵印山,覃海波,杨辉.奈达铂和氟尿嘧啶化疗联合同步放疗治疗Ⅲ、Ⅳa期鼻咽癌临床分析[J].现代肿瘤医学,2007,15(5):626-628. 被引量：10
-
6李冰,司勇锋,覃扬达,张政.奈达铂、卡铂联合氟尿嘧啶同期放化疗治疗中晚期鼻咽癌的不良反应对比[J].中国医药指南,2013,11(30):299-300. 被引量：1
-
7柴小郁.新辅助化疗方案在乳腺癌治疗中的应用效果观察[J].基层医学论坛,2014,18(29):3960-3961. 被引量：3
-
8莫艳艳.康艾注射液联合奥沙利铂、亚叶酸钙、氟尿嘧啶化疗治疗晚期胃癌临床分析[J].中华实用诊断与治疗杂志,2010,24(10):1008-1009. 被引量：10
-
9夏欣欣,韩黎丽,邓文英,许勇飞,罗素霞.乳腺、肾多原发恶性肿瘤一例并文献复习[J].中国实用医刊,2014,41(11):19-21.
-
10张秀辉,侯亚丽.不同化疗方案治疗胃癌的疗效分析[J].中国卫生产业,2013,10(30):167-167.
